Why Treg should be the focus of cancer immunotherapy: The latest thought - 11/11/23


Abstract |
Regulatory T cells are a subgroup of T cells with immunomodulatory functions. Different from most cytotoxic T cells and helper T cells, they play a supporting role in the immune system. What’s more, regulatory T cells often play an immunosuppressive role, which mainly plays a role in maintaining the stability of the immune system and regulating the immune response in the body. However, recent studies have shown that not only playing a role in autoimmune diseases, organ transplantation, and other aspects, regulatory T cells can also play a role in the immune escape of tumors in the body, through various mechanisms to help tumor cells escape from the demic immune system, weakening the anti-cancer effect in the body. For a better understanding of the role that regulatory T cells can play in cancer, and to be able to use regulatory T cells for tumor immunotherapy more quickly. This review focuses on the research progress of various mechanisms of regulatory T cells in the tumor environment, the related research of tumor cells acting on regulatory T cells, and the existing various therapeutic methods acting on regulatory T cells.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Unlike in the past, Treg cells have also been found to play a powerful role in cancer treatment. |
• | Treg cells exert immunosuppressive effects through various ways, such as cell-cell contact, secretion of cytokines, regulation of DC function, binding to chemokine CCL22/CCL17, and so on, and acting in the tumor microenvironment. |
• | Tumorigenesis is often accompanied by an increase in the number of Treg cells. |
• | Many recent studies have found that metabolic pathways, receptors, and proteins on Treg cells, bile acids, and even apoptotic Treg cells can promote Treg cells to exert immune suppression, and then help tumors escape from the immune system. |
• | More and more targeted therapy drugs that block the target sites on Treg cells and destroy the homeostasis between Th17 cells and Treg cells can be effective immunotherapy for tumors. |
Abbreviations : CBM, CTLA-4, DC, GITR, IL-2, IL-10, MCT1, PEP, SREBP, TCR, TGF-β, TME, Treg, VAT
Keywords : Immunosuppression therapy, Immune tolerance, Treg, Tumor immunotherapy, Tumor microenvironment
Plan
Vol 168
Article 115142- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?